Hyperion Defi Inc (HYPD) Stock Price, Quote & News

Company Profile

Hyperion DeFi, Inc. operates as a digital asset treasury and ophthalmic technology company in the United States. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It also develops the Optejet User Filled Device for horizontal, microdose spray delivery of ophthalmic liquids, such as artificial tears and lens rewetting products, as...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 393 6684

Website: hyperiondefi.com

Address:

23461 South Point Drive, Suite 390, Laguna Hills, United States

shade00tree May. 13 at 1:50 PM

$AEHL $HYPD hmm.

0 · Reply

Zaksab May. 12 at 3:42 PM

$HYPD that dilution was disgusting. Misaligned incentives between equity per share owners if they want to juice up the absolute gross assets and cream cash fees

0 · Reply

PhishTourFunds May. 10 at 6:42 PM

$HYPD Bounces here at $3.50 to make higher lows after round tripping ~20% this early March post

0 · Reply

ford11 May. 7 at 2:32 PM

$HYPD Looks like stres from dilution is over, it is setling in!!

0 · Reply

TomRozz May. 7 at 3:05 AM

$HYPD everyonr wants a dip, but when it comes everyone too afraid to buy 🤣

1 · Reply

bionicman1969 May. 6 at 4:11 PM

$HYPD avoid all stocks banked by Chardan

1 · Reply

SpencerF May. 6 at 3:51 PM

$HYPD worth adding? Or just let’r die?

1 · Reply

JaysLowFloatStock May. 6 at 3:34 PM

$HYPD

0 · Reply

URANIO_ARRICCHITO May. 6 at 2:50 PM

$HYPD In 50 years we will look back on today and, if we are alive, we will laugh... (I'm speechless!)

0 · Reply

Zaksab May. 6 at 2:10 PM

$HYPD what a beautiful way to punish your long suffering shareholders. Fucking bravo.

0 · Reply

Hyperion DeFi Announces Closing of Public Offering of Common Stock

2026-05-07T06:25:38.000Z - 6 days ago

Hyperion DeFi 2.777M share Spot Secondary priced at $3.60

May 6, 2026, 7:00 AM EDT - 7 days ago

Hyperion DeFi Announces Pricing of Public Offering of Common Stock

2026-05-05T20:25:18.000Z - 8 days ago

Hyperion DeFi announces common stock and warrants offering, no amount given

May 5, 2026, 4:01 PM EDT - 8 days ago

Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

May 1, 2026, 11:12 AM EDT - 12 days ago

Hyperion DeFi Schedules First Quarter Earnings Call for Thursday, May 14 at 8:00 a.m. ET

Apr 27, 2026, 10:50 AM EDT - 16 days ago

Hyperion DeFi Announces Participation in Upcoming Investor and Industry Conferences

Mar 26, 2026, 8:00 AM EDT - 6 weeks ago

Hyperion DeFi Earnings Call Transcript: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 6 weeks ago

Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit

2026-03-24T12:15:55.000Z - 7 weeks ago

Hyperion DeFi enters HAUS agreement with Silhouette

2026-03-09T12:17:14.000Z - 2 months ago

Hyperion DeFi engages HyperLend to create private lending pool

Mar 9, 2026, 8:00 AM EDT - 2 months ago

Hyperion DeFi Announces Private Lending Pool Built by HyperLend

2026-02-04T13:21:03.000Z - 3 months ago

Hyperion DeFi engages Rysk protocol for institutional volatility income vault

2026-01-12T13:41:13.000Z - 4 months ago

Hyperion DeFi issues letter to shareholders

2026-01-05T13:16:01.000Z - 4 months ago

Hyperion DeFi appoints Hyunsu Jung as CEO, effective immediately

2025-12-24T09:35:25.000Z - 5 months ago

Hyperion DeFi initiated with a Buy at Chardan

2025-12-16T14:47:00.000Z - 5 months ago

Cantor starts Hyperliquid treasury company Hyperion DeFi at Overweight

2025-12-16T11:45:31.000Z - 5 months ago

Hyperion DeFi initiated with an Overweight at Cantor Fitzgerald

2025-12-04T13:05:21.000Z - 5 months ago

Hyperion DeFi announces receipt of Kinetiq Airdrop

2025-11-17T13:05:31.000Z - 6 months ago

Hyperion DeFi files $1B mixed securities shelf

Nov 13, 2025, 5:00 PM EST - 6 months ago

Hyperion DeFi Earnings Call Transcript: Q3 2025

2025-10-29T12:05:43.000Z - 7 months ago

Hyperion DeFi, Felix partner for HIP-3 powered perpetual futures market

Sep 29, 2025, 8:00 AM EDT - 8 months ago

Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Sep 27, 2025, 7:30 AM EDT - 8 months ago

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

MARA MSTR

Sep 25, 2025, 8:00 AM EDT - 8 months ago

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Sep 16, 2025, 8:00 AM EDT - 8 months ago

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Aug 14, 2025, 10:16 AM EDT - 9 months ago

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Aug 13, 2025, 4:30 PM EDT - 9 months ago

Hyperion DeFi Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 9 months ago

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Aug 8, 2025, 4:05 PM EDT - 9 months ago

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Jul 29, 2025, 2:00 PM EDT - 10 months ago

Hyperion DeFi Transcript: Status Update

Jul 28, 2025, 8:00 AM EDT - 10 months ago

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Jul 17, 2025, 8:00 AM EDT - 10 months ago

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Jul 14, 2025, 4:05 PM EDT - 10 months ago

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Jun 18, 2025, 2:04 PM EDT - 11 months ago

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

KIDZ LGHL

Jun 18, 2025, 8:32 AM EDT - 11 months ago

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Jun 17, 2025, 3:54 PM EDT - 11 months ago

Eyenovia Surges on Crypto Announcement

Jun 17, 2025, 2:55 PM EDT - 11 months ago

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

May 19, 2025, 5:30 PM EDT - 1 year ago

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Apr 10, 2025, 7:00 AM EDT - 1 year ago

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Mar 20, 2025, 7:00 AM EDT - 1 year ago

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Feb 26, 2025, 7:00 AM EST - 1 year ago

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Feb 24, 2025, 7:00 AM EST - 1 year ago

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Feb 5, 2025, 7:00 AM EST - 1 year ago

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Jan 28, 2025, 4:05 PM EST - 1 year ago

Eyenovia Announces 1-for-80 Reverse Stock Split

Jan 15, 2025, 7:00 AM EST - 1 year ago

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Jan 6, 2025, 7:00 AM EST - 1 year ago

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Dec 6, 2024, 8:00 AM EST - 1 year ago

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Nov 22, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Restructuring Efforts

Nov 15, 2024, 7:07 AM EST - 1 year ago

Eyenovia to discontinue late-stage study for eye drug

Nov 15, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Nov 12, 2024, 4:30 PM EST - 1 year ago

Hyperion DeFi Earnings Call Transcript: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Oct 16, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Oct 1, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Sep 27, 2024, 8:30 AM EDT - 1 year ago

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Sep 26, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Sep 9, 2024, 3:00 AM EDT - 1 year ago

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Sep 5, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Aug 23, 2024, 11:42 AM EDT - 1 year ago

Eyenovia Announces Closing of Public Offering

Aug 21, 2024, 9:29 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5.14 Million Public Offering

Aug 20, 2024, 5:09 PM EDT - 1 year ago

Eyenovia, Inc. Announces Proposed Public Offering

Aug 12, 2024, 4:30 PM EDT - 1 year ago

Hyperion DeFi Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Aug 7, 2024, 5:11 PM EDT - 1 year ago

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

shade00tree May. 13 at 1:50 PM

$AEHL $HYPD hmm.

0 · Reply

Zaksab May. 12 at 3:42 PM

$HYPD that dilution was disgusting. Misaligned incentives between equity per share owners if they want to juice up the absolute gross assets and cream cash fees

0 · Reply

PhishTourFunds May. 10 at 6:42 PM

$HYPD Bounces here at $3.50 to make higher lows after round tripping ~20% this early March post

0 · Reply

ford11 May. 7 at 2:32 PM

$HYPD Looks like stres from dilution is over, it is setling in!!

0 · Reply

TomRozz May. 7 at 3:05 AM

$HYPD everyonr wants a dip, but when it comes everyone too afraid to buy 🤣

1 · Reply

bionicman1969 May. 6 at 4:11 PM

$HYPD avoid all stocks banked by Chardan

1 · Reply

SpencerF May. 6 at 3:51 PM

$HYPD worth adding? Or just let’r die?

1 · Reply

JaysLowFloatStock May. 6 at 3:34 PM

$HYPD

0 · Reply

URANIO_ARRICCHITO May. 6 at 2:50 PM

$HYPD In 50 years we will look back on today and, if we are alive, we will laugh... (I'm speechless!)

0 · Reply

Zaksab May. 6 at 2:10 PM

$HYPD what a beautiful way to punish your long suffering shareholders. Fucking bravo.

0 · Reply

Huustle May. 6 at 2:08 PM

$HYPD I bought more at 3.34. Little over 7% below offering price. I believe in $HYPE.X longer term appreciation and think management here knows how to squeeze the most out of that lemon. Unfortunate they had to dilute.

0 · Reply

cheating_stock_trader May. 6 at 1:49 PM

$HYPD buying more here. This is avenue capital most likely dumping their shares. Toxic lenders are bad for micro cap companies and they are moving on. See you at 5+ next week.

1 · Reply

Huustle May. 6 at 1:47 PM

$HYPD I'd rather the company stock be 25% higher like yesterday and not diluted by 30%.... killed all momentum in this thing. Diluted a large percentage at major discount to stock price. I get they think HYPE is going much higher and more funds means more appreciation on their eventual holdings, but this hurts as a shareholder.

1 · Reply

YorkMeister May. 6 at 1:28 PM

$HYPD please explain this pricing soon. This was already at a 50% NAV discount and the hypd story is one of a superior model for revenue creation, not a straightforward hype treasury company . Show why this is a good investment thesis , compared to $PURR which is up 80% from February lows of hypx while raising funds.

1 · Reply

cheating_stock_trader May. 6 at 1:27 PM

$HYPD my assumption is logically based on either the real world likelihood of the following 2 situations 1. The closing of Optejet is based on the approval of avenue capital and they wouldnt sign off on the structure so company just wants to pay them off now asap. Or the unfortunate scenario is 2. Optejet was found to be useless and a scam on rowe and previous management did some bad things and they just need to scrap it and pay down avenue to just move forward. Rather than go through a legal mess dragging down ops they just need to deal with this and move on with business. Those things can be handled later but first need to remove overhang of avenue. Both cases above are evident avenue is a toxic lender and they need to be eliminated asap to get shareprice back to a premium of nav. It is evident someone is also short here looking to exit as certain articles such as the one i posted on notxnote was published most recently. I anticipate stock price going back over 5 in a week after everything is disclosed and resolved.

0 · Reply

SpencerF May. 6 at 1:16 PM

$HYPD $3.60 offering so mandatory drip to $1.80 then?

0 · Reply

SpencerF May. 6 at 1:15 PM

$HYPD confirmed company is over? Or still worth holding?

1 · Reply

OpenOutcrier May. 6 at 12:53 PM

$HYPD (-20.8% pre) Hyperion DeFi prices $10 million public stock offering at $3.60 per share https://ooc.bz/l/101294

0 · Reply

DARKP00L May. 6 at 12:46 PM

$HYPD 07:16 on May. 06 2026 Hyperion DeFi Prices Public Offering Of 2,777,778 Shares At $3.60 Per Share #tradeideas

0 · Reply

taylorlee26 May. 6 at 12:34 PM

$HYPD Mgmt wtf are u doing Why now? Not Feb? Most stupid choice I've ever seen

0 · Reply

YorkMeister May. 6 at 11:52 AM

$HYPD anyway bring it back to 3.60 and I buy my swings back

0 · Reply

YorkMeister May. 6 at 11:47 AM

$HYPD okay that seems very cheap, must be a reason for it. Damn they could have done this in feb 😵‍💫. They gave some explaining to do on the call. But it doesn’t matter much for medium term

1 · Reply

Market Cap	44.36M
Revenue (ttm)	810,000.00
Net Income (ttm)	-45.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	1.25
Profit Margin	-5,593.83%
Debt to Equity Ratio	0.19

Volume	464,400
Avg Vol	410,446
Day's Range	N/A - N/A
Shares Out	12.22M
Stochastic %K	12%
Beta	2.57
Analysts	Sell
Price Target	$6.28